These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16478526)

  • 1. The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents.
    Montezinho LP; Castro MM; Duarte CB; Penschuck S; Geraldes CF; Mørk A
    J Neurochem; 2006 Mar; 96(5):1336-48. PubMed ID: 16478526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors.
    Montezinho LP; Mørk A; Duarte CB; Penschuck S; Geraldes CF; Castro MM
    Bipolar Disord; 2007 May; 9(3):290-7. PubMed ID: 17430304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent.
    Beazely MA; Tong A; Wei WL; Van Tol H; Sidhu B; MacDonald JF
    J Neurochem; 2006 Sep; 98(5):1657-63. PubMed ID: 16879713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical regulation of dopamine receptors in transfected 293 cells.
    Filtz TM; Artymyshyn RP; Guan W; Molinoff PB
    Mol Pharmacol; 1993 Aug; 44(2):371-9. PubMed ID: 8102783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.
    Mann L; Heldman E; Bersudsky Y; Vatner SF; Ishikawa Y; Almog O; Belmaker RH; Agam G
    Bipolar Disord; 2009 Dec; 11(8):885-96. PubMed ID: 19922557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
    Ramanathan S; Tkatch T; Atherton JF; Wilson CJ; Bevan MD
    J Neurophysiol; 2008 Feb; 99(2):442-59. PubMed ID: 18094105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic activation of the D2 dopamine autoreceptor inhibits synaptogenesis in mesencephalic dopaminergic neurons in vitro.
    Fasano C; Poirier A; DesGroseillers L; Trudeau LE
    Eur J Neurosci; 2008 Oct; 28(8):1480-90. PubMed ID: 18973573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-induced changes in beta adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex.
    Dibner MD; Molinoff PB
    J Pharmacol Exp Ther; 1979 Sep; 210(3):433-9. PubMed ID: 39161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus.
    Fumagalli F; Bedogni F; Maragnoli ME; Gennarelli M; Perez J; Racagni G; Riva MA
    J Neurosci Res; 2003 Oct; 74(1):74-80. PubMed ID: 13130508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
    Rouillon C; Abraini JH; David HN
    Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J; Dougherty JJ; Nichols RA
    J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic valproate fails to prevent imipramine-induced behavioural sensitization to the dopamine D2-like receptor agonist quinpirole.
    D'Aquila PS; Panin F; Serra G
    Eur J Pharmacol; 2006 Mar; 535(1-3):208-11. PubMed ID: 16533507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice.
    Umeda K; Suemaru K; Todo N; Egashira N; Mishima K; Iwasaki K; Fujiwara M; Araki H
    Eur J Pharmacol; 2006 Dec; 553(1-3):157-62. PubMed ID: 17070517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells.
    Conde SV; Gonzalez C; Batuca JR; Monteiro EC; Obeso A
    J Neurochem; 2008 Dec; 107(5):1369-81. PubMed ID: 18823369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
    Tozzi A; Tscherter A; Belcastro V; Tantucci M; Costa C; Picconi B; Centonze D; Calabresi P; Borsini F
    Neuropharmacology; 2007 Nov; 53(6):783-9. PubMed ID: 17889039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
    Vortherms TA; Watts VJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.
    Basselin M; Chang L; Chen M; Bell JM; Rapoport SI
    Neurochem Res; 2008 Jul; 33(7):1373-83. PubMed ID: 18302021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.